Deep sequencing of plasma and proviral HIV-1 to establish coreceptor usage: what is the clinical impact of the quasispecies distribution?

MLA

Abbate, Isabella, et al. “Deep Sequencing of Plasma and Proviral HIV-1 to Establish Coreceptor Usage: What Is the Clinical Impact of the Quasispecies Distribution?” The Journal of Infectious Diseases, vol. 204, no. 6, Sept. 2011, pp. 971–73. EBSCOhost, https://doi.org/10.1093/infdis/jir427.

APA

Abbate, I., Rozera, G., Giombini, E., D’Offizi, G., Nicastri, E., Narciso, P., Ippolito, G., & Capobianchi, M. R. (2011). Deep sequencing of plasma and proviral HIV-1 to establish coreceptor usage: what is the clinical impact of the quasispecies distribution? The Journal of Infectious Diseases, 204(6), 971–973. https://doi.org/10.1093/infdis/jir427

Chicago

Abbate, Isabella, Gabriella Rozera, Emanuela Giombini, Gianpiero D’Offizi, Emanuele Nicastri, Pasquale Narciso, Giuseppe Ippolito, and Maria R Capobianchi. 2011. “Deep Sequencing of Plasma and Proviral HIV-1 to Establish Coreceptor Usage: What Is the Clinical Impact of the Quasispecies Distribution?” The Journal of Infectious Diseases 204 (6): 971–73. doi:10.1093/infdis/jir427.